APhA needs your assistance to ensure you can effectively care for you patients. Reach out to your Member of Congress and Senators and ask them to take immediate action to provide adequate, appropriate, and fair payment for pharmacist consultations and services for prescribing Paxlovid.
We’re excited to announce the launch of the new APhA Learning Library! This new platform will make it easier than ever for you to get the education you need. Read about some key highlights of our new system.
APhA is committed to facilitating meaningful dialogue between pharmacy management, pharmacy team members, and other stakeholders that result in improved workplaces, well-being, and ability to meet ethical obligations to patient safety.
Tips From the Field: Safe & Timely Vaccinations
Tools and resources to support your practice
APhA’s monthly Pulse on Practice and Policy Open Forum Series creates a platform where all of pharmacy can come together to share perspectives and be informed of key practices and policies impacting the profession.
An APhA member-only resource for pharmacists, pharmacy residents, student pharmacists, pharmacy technicians, and interprofessional health care team members involved in providing transitions of care (TOC) services.
An outline of the key steps to implementing monoclonal antibody therapy administration services in community settings.
View CEO Blog
A letter from Interim CEO Ilisa Bernstein, PharmD, JD, FAPhA, to Dr. Robert Califf, Commissioner of the Food and Drug Administration (FDA), on the importance of pharmacists being allowed to prescribe oral COVID-19 treatments.
View all press releases
(July 25, 2022) WASHINGTON, DC— For the past month, the American Pharmacists Association (APhA) has been advocating for patients and pharmacists regarding the Dobbs v Jackson Supreme Court decision. This work has included engaging with members
View all news
Fetal drug overdoses in the United States soared 30% in 2020, the most recent CDC statistics show, but the burden on minority populations has grown exponentially due to fewer treatment options.
Roughly one month after FDA authorized COVID-19 vaccines for very young children, it does not appear that large numbers of them will actually get vaccinated, according to a new Kaiser Family Foundation survey of parents. Most parents said they considered the vaccine a greater risk to their children than COVID-19.